Bingyi Yang

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Fat reduction mediates the efficacy of intensive lifestyle interventions on fertility-sparing treatment in overweight patients with endometrial cancer and intraepithelial neoplasia.

Fat reduction mediates the efficacy of intensive lifestyle interventions on fertility-sparing treatment in overweight patients with endometrial cancer and intraepithelial neoplasia.

Journal: Acta obstetricia et gynecologica Scandinavica

Published: October 19, 2025

Cholesterol desensitizes the response of endometrial cancer to progestin by attenuating progestin signaling.

Cholesterol desensitizes the response of endometrial cancer to progestin by attenuating progestin signaling.

Journal: Science translational medicine

Published: October 01, 2025

Effects of levonorgestrel-releasing intrauterine system on recurrence and fertility outcomes during assisted reproduction after complete remission of early endometrioid endometrial cancer and precancerous lesions: A retrospective cohort study.

Effects of levonorgestrel-releasing intrauterine system on recurrence and fertility outcomes during assisted reproduction after complete remission of early endometrioid endometrial cancer and precancerous lesions: A retrospective cohort study.

Journal: International journal of cancer

Published: November 26, 2024

Pregnancy complications and outcomes in patients with early endometrial cancer or atypical hyperplasia after fertility-sparing treatment.

Pregnancy complications and outcomes in patients with early endometrial cancer or atypical hyperplasia after fertility-sparing treatment.

Journal: Journal of gynecologic oncology

Published: September 08, 2024

Deleterious variants in RNF111 impair female fertility and induce premature ovarian insufficiency in humans and mice.

Deleterious variants in RNF111 impair female fertility and induce premature ovarian insufficiency in humans and mice.

Journal: Science China. Life sciences

Published: April 18, 2024

Clinicopathological characteristics and fertility preserving treatment of atypical polypoid adenomyoma.

Clinicopathological characteristics and fertility preserving treatment of atypical polypoid adenomyoma.

Journal: Frontiers in oncology

Published: February 16, 2024

Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective, open-label, randomized controlled phase II trial (ClinicalTrials.gov NCT03241914).

Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective, open-label, randomized controlled phase II trial (ClinicalTrials.gov NCT03241914).

Journal: Journal of gynecologic oncology

Published: August 31, 2022

Thyroid Hormone Receptor β Knockdown Reduces Suppression of Progestins by Activating the mTOR Pathway in Endometrial Cancer Cells.

Thyroid Hormone Receptor β Knockdown Reduces Suppression of Progestins by Activating the mTOR Pathway in Endometrial Cancer Cells.

Journal: International journal of molecular sciences

Published: August 13, 2022

Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: A prospective, open-label, randomized controlled phase II study.

Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: A prospective, open-label, randomized controlled phase II study.

Journal: Gynecologic oncology

Published: June 02, 2022

Endometrium-derived mesenchymal stem cells suppress progression of endometrial cancer via the DKK1-Wnt/β-catenin signaling pathway.

Endometrium-derived mesenchymal stem cells suppress progression of endometrial cancer via the DKK1-Wnt/β-catenin signaling pathway.

Journal: Stem cell research & therapy

Published: May 11, 2022

NrCAM secreted by endometrial stromal cells enhances the progestin sensitivity of endometrial cancer cells through epigenetic modulation of PRB.

NrCAM secreted by endometrial stromal cells enhances the progestin sensitivity of endometrial cancer cells through epigenetic modulation of PRB.

Journal: Cancer gene therapy

Published: September 26, 2021

Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment.

Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment.

Journal: Journal of gynecologic oncology

Published: November 18, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026